Targeting efficiency of PEG-immunoliposome-conjugated antibodies at PEG terminals

Advanced Drug Delivery Reviews

Volumn 24, Issue 2-3, 1997, Pages 235-242

  Maruyama, Kazuo ^a   Takizawa, Tomoko ^a   Takahashi, Nobuya ^a   Tagawa, Toshiaki ^b   Nagaike, Kazuhiro ^b   Iwatsuru, Motoharu ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

drug delivery system; Fab' fragment; immunoliposome; liposome; polyethyleneglycol

Indexed keywords

AMINO ACIDS; ANTIBODIES; BIOASSAY; CELLS; CHOLESTEROL; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; IMMUNOLOGY; LIPIDS; POLYETHYLENE GLYCOLS;

CELL BINDING ASSAY; FAB FRAGMENT; IMMUNOLIPOSOME; LIPOSOMES; PASSIVE CONVECTIVE TRANSPORT;

PHARMACOKINETICS;

CARBOXYL GROUP; CARCINOEMBRYONIC ANTIGEN; CHOLESTEROL; CHOLESTERYL HEXADECYL ETHER; DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; DISTEAROYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLETHANOLAMINE; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOLIPOSOME; MACROGOL; MACROGOL DERIVATIVE; MALEIMIDE DERIVATIVE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 21B2; MONOCLONAL ANTIBODY 34A; N GLUTARYL DISTEAROYLPHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLCHOLINE; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER GRAFT; CONFERENCE PAPER; CONJUGATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG SYNTHESIS; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LUNG ENDOTHELIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SOLID TUMOR; STOMACH CANCER; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM;

EID: 0343196666     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(96)00463-2     Document Type: Conference Paper

References (22)

1. Aragnol, D. and Leserman, L.D. (1986) Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo. Proc. Natl. Acad. Sci. USA 83, 2699-2703.
2. Derksen, J.T.P., Marselt, H.W.M. and Scherphof, G.L. (1988) Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages. Biochim. Biophys. Acta 971, 127-136.
3. Maruyama, K., Holmberg, E., Kennel, S.J. Klibanov, A., Torehilin V.P. and Huang, L. (1990) Characterization of in vivo immunoliposome targeting to pulmonary endothelium. J. Pharm. Sci. 79, 978-984.
4. Klibanov, A., Maruyama, K., Torchilin V.P. and Huang, L. (1990) Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268, 235-237.
5. Blume, G. and Cevc, G. (1990) Liposomes for sustained drug release in vivo. Biochim. Biophys. Acta 1029, 91-97.
6. Allen, T.M., Hansen, C., Martin, F., Redemann, C. and Young, A.Y. (1991) Biochim. Biophys, Acta 1066, 29-36.
7. Maruyama, K., Yuda, T., Okamoto, S., Kojima, S., Suginaka, A. and Iwatsuru, M. (1992) Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoylphosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim. Biophys. Acta 1128, 44-49.
8. Maruyama, K., Takizawa, T., Yuda, Kennel, S.J., Huang, L. and Iwatsuru, M. (1995) Targetability of novel immunoliposomes modified with amphipathic polyethyleneglycols conjugated at their distal terminals to monoclonal antibodies. Biochim. Biophys. Acta 1234, 74-80.
9. European patent publication No. 607978.
10. Weissig,V., Lasch, J., Klibanov, A. and Torchilin V.P. (1986) A new hydrophobic anchor for the attachment of proteins to liposomal membranes. FEBS Lett 202, 86-90.
11. Hughes, B., Kennel, S.J., Lee, R. and Huang, L. (1989) Monoclonal antibody targeting of liposomes to mouse lung in vivo. Cancer Res. 49, 6214-6220.
12. Uyama, I., Kumai, K., Yasuda, T., Tagawa, T., Ishibiki, K., Kitajima, M. and Tadakuma, T. (1994) Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes. Jpn. J. Cancer Res. 85, 434-440.
13. Ishikawa, E., Imagawa, H., Hashida, S., Yashitake, S., Hamaguchi, Y. and Ueno, T. (1983) Enzyme labeling antibodies and their fragments for enzyme immunoassay and immunohistochemical staining. J. Immunoassay 4, 209-327.
14. Geran, R., Greenberg, N., MacDonald, M., Schmacner, A. and Abott, B. (1972) Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother. Res. 3, 1-85.
15. Szoka, F. and Papahadjopoulos, D. (1978) Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci. USA 75, 4194-4198.
16. Enoch, H.G. and Strittmatter, P. (1979) Formation and properties of 1000-Å-diameter, single-bilayer phospholipid vesicles. Proc. Natl. Acad. Sci. USA 76, 145-149.
17. Wu, M., Robbins, J., Bugianesi, R., Ponpipom, M. and Shen, T.Y. (1981) Modified in vivo behavior of liposomes containing synthetic glycolipids. Biochim. Biophys. Acta 674, 19-26.
18. Maruyama, K., Unezaki, S., Takahashi, N. and Iwatsuru, M. (1993) Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. Biochim. Biophys. Acta 1149, 209-216.
19. Jain, R.K. and Gerlowski, L.E. (1986) Extravascular transport in normal and tumor tissue. Crit. Rev. Oncol. Hematol. 5, 115-170.
20. Gabizon, A. and Papahadjopoulos, D. (1988) Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA 77, 459-467.
21. Forssen, E.A., Coulter, D.M. and Proffitt, R.T. (1992) Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. Cancer Res. 52, 3255-3261.
22. Unezaki, S. Maruyama, K., Hosoda, J., Nagae, I., Ishida, Y., Nakata, M., Ishida, O., Iwatsuru, M. and Tsuchiya, S. (1996) Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy. Int. J. Pharm. in press.